Taken together, these data indicate that metabolic pathways, cell cycle, apoptosis, and insulin and VEGF signalling are unique targets of stress-induced ATF3, whereas diabetes mellitus and calcium signalling, but not cell cycle and apoptosis, are unique targets of ATF3 expressed in cancer cells. Here, VEGFA is linked to cancer.